medigraphic.com
SPANISH

Revista Cubana de Medicina Militar

ISSN 1561-3046 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2021, Number 3

<< Back Next >>

Rev Cub Med Mil 2021; 50 (3)

Hemoperitoneum secondary to rupture of hepatocellular carcinoma

Espinosa RY, Fuentes RJ, Bonachea PRR, Betancourt CJR
Full text How to cite this article

Language: Spanish
References: 11
Page:
PDF size: 376.45 Kb.


Key words:

hepatocellular carcinoma, liver cirrhosis, hemoperitoneum.

ABSTRACT

Introduction: Hepatocellular carcinoma is a hypervascular tumor made up of abnormal blood vessels. It is the most frequent form of primary liver cancer. About 90 % of these tumors develop over a previous liver disease. An increase in vascular load due to portal hypertension leads to bleeding.
Objective: To present a patient who underwent emergency exploratory laparotomy due to large hemoperitoneum secondary to an intratumoral rupture of a cirrhotic liver.
Clinical case: A 66-year-old male patient with a pathological history of type 2 diabetes mellitus, benign prostatic hyperplasia, chronic alcoholism and liver cirrhosis. He came to emergency due to diffuse abdominal pain, as well as signs of acute hypovolemia. An emergency laparotomy was performed, confirming a large hemoperitoneum secondary to an intratumoral rupture. Blood content aspiration, electrocoagulation and compression by packing were performed, managing to control bleeding. He had a torpid evolution, dying 24 hours after the laparotomy.
Conclusions: Hemoperitoneum secondary to rupture of a hepatocellular carcinoma is a rare, but fatal complication; therefore, its study is necessary to achieve a timely diagnosis and treatment.


REFERENCES

  1. Sánchez R, Salas M, Diamante C, Bravo JC, Arcos M. Hemoperitoneo como manifestación inicial de carcinoma hepatocelular: reporte de tres casos. Gastroenterol. Latinoam. 2018 [acceso: 13/05/2020];29(1):27-32. Disponible en: Disponible en: https://gastrolat.org/hemoperitoneo-como-manifestacion-inicial-de-carcinoma-hepatocelular-reporte-de-tres-casos/

  2. Arellano N, Páez L, Arellano C. Carcinoma hepatocelular sobre enfermedad de hígado graso no alcohólico. 2018 [acceso: 11/05/2020];51(3):93-98. Disponible en: http://dx.doi.org/10.18004/anales/2018.051(03)93-098

  3. Ayala-Haro N, Sandoval-Illescas MC, Martínez-Navarro LJ, Cruz-Fabián S. Hemoperitoneo en pacientes con cirrosis hepática. Evidencia Médica e Investigación en Salud. 2015 [acceso: 22/04/2020];8(3):128-131. Disponible en: Disponible en: https://biblat.unam.mx/hevila/Evidenciamedicaeinvestigacionensalud/2015/vol8/no3/5.pdf

  4. Pinal-García DF, Nuño-Guzmán CM, Gómez-Abarca A, Corona JL, Espejo I. Spontaneous rupture of hepatocelular carcinoma in a young patient with fatal outcome. Case Repor Gastroenterol. 2018 [acceso: 22/04/2020];12:19-26. Disponible en: http://doi.org/10.1159/000486193

  5. Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, Kalra N, Gorsi U. Rupture of hepatocellular Carcinoma: a review of Literature. J Clin Exp Hepatol. 2019 [acceso: 22/03/2020];9(2):245-256. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31024207/

  6. Tanaka S, Kaibori M, Ueno M, Wada H, Hirokawa F, Nakai T, et al. Surgical outcomes for the ruptured hepatocellular carcinoma: multicenter analysis with a case-controlled study. J Gastrointest Surg. 2016 [acceso: 15/02/2020];20:2021-34. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/27718151/

  7. Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology and carcinogenesis. J Carcinog. 2017 [acceso: 15/02/2020];16(1):9-16. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28694740/

  8. Schwarz L, Bubenheim M, Zemour J, Herrero A, Muscari F, Ayav A. Bleeding recurrence and mortality following interventional management of spontaneous HCC rupture: Results of a multicenter European study. World J Surg. 2018 [acceso: 15/02/2020];42:225-232. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28799103/

  9. Balsano C, Porcu C, Sideri S, Tavolaro S. Fat and hepatocellular carcinoma. Hepatoma Res. 2018 [13/05/2020];4:38. Disponible en: http://dx.doi.org/10.20517/2394-5079.2018.51

  10. Zhong F, Cheng XS, He K, Sun SB, Zhou J, Chen HM. Treatment outcomes of spontaneous rupture of hepatocellular carcinoma with hemorrhagic shock: a multicenter study. Springerplus. 2016 [acceso: 15/02/2020];5(1):1101. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947465/

  11. Yoshida H, Mamada Y, Taniai N, Uchida E. Spontaneous ruptured hepatocellular carcinoma. Hepatol Res. 2016 [acceso: 15/04/2020];46:13-21. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/25631290/




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Med Mil . 2021;50